Video: Leaked Internal Emails from the European Medicines Agency (EMA) and Meeting Report Between the Agency and Pfizer. Corona Investigative Committee with Sonia Elijah
All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
***
Guest: Sonia Elijah, investigative journalist and broadcaster at trialsitenews.com. She has a background in Economics and was a former BBC researcher. Her analysis of the Pfizer COVID vaccine safety report received worldwide attention.
This session reviews the leaked internal emails from the European Medicines Agency (EMA) and meeting report between the agency and Pfizer.
The US and EU government officials pressured European drug regulators to rush the approval of Pfizer-BioNTech’s COVID-19 vaccine despite safety concerns; including direct lobbying by Pfizer CEO Albert Bourla to the President of the EU Commission and a high-level FDA regulator.
Video
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
